# OnCo record inv-6452 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/inv-6452/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "inv-6452" ;
  schema:name "INV-6452"@en ;
  schema:description "INV-6452 is an experimental form not stated by the company or the registry from Shenzhen Ionova Life Sciences, in phase 1 trials for HR-positive HER2-negative breast cancer, ovarian cancer and endometrial cancer."@en ;
  schema:url <https://onco.cc/drugs/inv-6452/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT07612891>, <https://clinicaltrials.gov/api/v2/studies/NCT07612891>, <https://clinicaltrials.gov/search?intr=INV-6452> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Form not stated by the company or the registry (oral)" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/> ;
  onco:companies <https://onco.cc/companies/shenzhen-ionova-life-sciences/> ;
  onco:trials <https://onco.cc/trials/nct07612891/> .